Centene (CNC) is back in focus after portfolio managers highlighted the stock’s strong reaction to better-than-expected quarterly results, pointing to stabilizing medical cost trends and management expense efforts as key drivers of shifting investor expectations.

At a share price of $68.29, Centene’s recent momentum is clear, with a 90 day share price return of 83.28% and a 1 year total shareholder return of 122.88% reflecting how quickly sentiment has shifted after the earnings surprise and improving medical cost signals.

If Centene’s rebound has you rethinking where growth and efficiency might meet in healthcare, it could be a good moment to scan 40 healthcare AI stocks

After Centene’s sharp move to $68.29, the stock now sits above the average analyst target while some intrinsic value estimates still point much higher. Where does a reasonable view of fair value actually land?

Most Popular Narrative: 14.6% Undervalued

Centene’s most followed narrative pegs fair value at $80, above the last close of $68.29. This frames the recent rally as still leaving room in the model.

Ongoing digital transformation and AI-driven payment integrity initiatives are set to deliver structural cost reductions and superior medical loss ratio management, creating the potential for sustained improvement in operating margins beyond peers as Centene benefits from both scale and technology investments.

Want to see what this margin story really assumes? The narrative leans on steadier government programs, rising profitability, and a future earnings profile that looks very different from today.

Result: Fair Value of $80 (UNDERVALUED)

However, the Centene story also depends on stable government reimbursement and medical cost trends, and any policy shift or sustained cost pressure could quickly challenge that optimistic view.

Next Steps

With sentiment on Centene split between optimism and caution, it makes sense to review the full picture yourself and move quickly to shape your own view using the 3 key rewards and 1 important warning sign

Looking for more investment ideas beyond Centene?

If Centene has sharpened your focus on where risk and reward can meet, do not stop here. Broaden your watchlist with other opportunities before they move away.

• Chase potential mispricing by scanning companies that screen as quality and undervalued through the 46 high quality undervalued stocks.
• Prioritize resilience by focusing on businesses that pair lower risk profiles with sturdier fundamentals using the 80 resilient stocks with low risk scores.
• Spot under-the-radar opportunities early by checking a screener containing 20 high quality undiscovered gems.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.